These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 39090657)

  • 1. The effects of probiotic supplementation and exercise training on liver enzymes and cardiometabolic markers in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomized clinical trials.
    Kazeminasab F; Miraghajani M; Mokhtari K; Karimi B; Rosenkranz SK; Santos HO
    Nutr Metab (Lond); 2024 Aug; 21(1):59. PubMed ID: 39090657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of carnitine supplementation on clinical characteristics of patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials.
    Abolfathi M; Mohd-Yusof BN; Hanipah ZN; Mohd Redzwan S; Yusof LM; Khosroshahi MZ
    Complement Ther Med; 2020 Jan; 48():102273. PubMed ID: 31987257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of probiotics on nonalcoholic fatty liver disease: a meta-analysis.
    Ma YY; Li L; Yu CH; Shen Z; Chen LH; Li YM
    World J Gastroenterol; 2013 Oct; 19(40):6911-8. PubMed ID: 24187469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Synbiotics, Probiotics, and Prebiotics on Liver Enzymes of Patients With Non-alcoholic Fatty Liver Disease: A Systematic Review and Network Meta-Analysis.
    Kanchanasurakit S; Kositamongkol C; Lanoi K; Nunta M; Saetuan T; Chaiyakunapruk N; Saokaew S; Phisalprapa P
    Front Nutr; 2022; 9():880014. PubMed ID: 35669067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of dapagliflozin in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials.
    Sun L; Deng C; Gu Y; He Y; Yang L; Shi J
    Clin Res Hepatol Gastroenterol; 2022 Apr; 46(4):101876. PubMed ID: 35321843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curcumin effects on glycaemic indices, lipid profile, blood pressure, inflammatory markers and anthropometric measurements of non-alcoholic fatty liver disease patients: A systematic review and meta-analysis of randomized clinical trials.
    Ebrahimzadeh A; Mohseni S; Safargar M; Mohtashamian A; Niknam S; Bakhoda M; Afshari S; Jafari A; Ebrahimzadeh A; Fooladshekan S; Mohtashami A; Ferns GA; Babajafari S; Sohrabi Z
    Complement Ther Med; 2024 Mar; 80():103025. PubMed ID: 38232906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of dietary polyphenol supplementation in the treatment of non-alcoholic fatty liver disease: A systematic review and meta-analysis.
    Yang K; Chen J; Zhang T; Yuan X; Ge A; Wang S; Xu H; Zeng L; Ge J
    Front Immunol; 2022; 13():949746. PubMed ID: 36159792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of intermittent fasting regimens on glycemic, hepatic, anthropometric, and clinical markers in patients with non-alcoholic fatty liver disease: Systematic review and meta-analysis of randomized controlled trials.
    Saleh SAK; Santos HO; Găman MA; Cerqueira HS; Zaher EA; Alromaih WR; Arafat NS; Adi AR; Adly HM; Alyoubi R; Alyahyawi N; Kord-Varkaneh H
    Clin Nutr ESPEN; 2024 Feb; 59():70-80. PubMed ID: 38220409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Different Exercise Methods on Non-Alcoholic Fatty Liver Disease: A Meta-Analysis and Meta-Regression.
    Xiong Y; Peng Q; Cao C; Xu Z; Zhang B
    Int J Environ Res Public Health; 2021 Mar; 18(6):. PubMed ID: 33801028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GLP-1 Receptor Agonist Effects on Lipid and Liver Profiles in Patients with Nonalcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis.
    Rezaei S; Tabrizi R; Nowrouzi-Sohrabi P; Jalali M; Atkin SL; Al-Rasadi K; Jamialahmadi T; Sahebkar A
    Can J Gastroenterol Hepatol; 2021; 2021():8936865. PubMed ID: 34805029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prebiotic and probiotic treatment of nonalcoholic fatty liver disease: a systematic review and meta-analysis.
    Loman BR; Hernández-Saavedra D; An R; Rector RS
    Nutr Rev; 2018 Nov; 76(11):822-839. PubMed ID: 30113661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of resveratrol on lipid profiles and liver enzymes in patients with metabolic syndrome and related disorders: a systematic review and meta-analysis of randomized controlled trials.
    Akbari M; Tamtaji OR; Lankarani KB; Tabrizi R; Dadgostar E; Haghighat N; Kolahdooz F; Ghaderi A; Mansournia MA; Asemi Z
    Lipids Health Dis; 2020 Feb; 19(1):25. PubMed ID: 32066446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of a fruit-rich diet on liver biomarkers, insulin resistance, and lipid profile in patients with non-alcoholic fatty liver disease: a randomized clinical trial.
    Alami F; Alizadeh M; Shateri K
    Scand J Gastroenterol; 2022 Oct; 57(10):1238-1249. PubMed ID: 35710164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial effects of probiotic and synbiotic supplementation on some cardiovascular risk factors among individuals with prediabetes and type 2 diabetes mellitus: A grade-assessed systematic review, meta-analysis, and meta-regression of randomized clinical trials.
    Naseri K; Saadati S; Yari Z; Asbaghi O; Hezaveh ZS; Mafi D; Hoseinian P; Ashtary-Larky D; Hekmatdoost A; de Courten B
    Pharmacol Res; 2022 Aug; 182():106288. PubMed ID: 35680009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of intermittent fasting combined with physical exercise on cardiometabolic outcomes: systematic review and meta-analysis of clinical studies.
    Kazeminasab F; Baharlooie M; Karimi B; Mokhtari K; Rosenkranz SK; Santos HO
    Nutr Rev; 2023 Dec; ():. PubMed ID: 38102800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic Review with Meta-Analysis: The Effects of Probiotics in Nonalcoholic Fatty Liver Disease.
    Xiao MW; Lin SX; Shen ZH; Luo WW; Wang XY
    Gastroenterol Res Pract; 2019; 2019():1484598. PubMed ID: 31885541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin supplementation effect on liver enzymes in patients with nonalcoholic fatty liver disease: a GRADE-assessed systematic review and dose-response meta-analysis of randomized controlled trials.
    Vajdi M; Hassanizadeh S; Hassanizadeh R; Bagherniya M
    Nutr Rev; 2024 Jan; ():. PubMed ID: 38213188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probiotics improve renal function, glucose, lipids, inflammation and oxidative stress in diabetic kidney disease: a systematic review and meta-analysis.
    Dai Y; Quan J; Xiong L; Luo Y; Yi B
    Ren Fail; 2022 Dec; 44(1):862-880. PubMed ID: 35611435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of coenzyme Q10 supplementation on lipid profiles and liver enzymes of nonalcoholic fatty liver disease (NAFLD) patients: A systematic review and meta-analysis of randomized controlled trials.
    Ardekani A; Tabrizi R; Maleki E; Bagheri Lankarani K; Heydari ST; Moradinazar M; Akbari M
    Food Sci Nutr; 2023 Jun; 11(6):2580-2588. PubMed ID: 37324909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of probiotic administration on patients with prediabetes: a meta-analysis and systematic review.
    Li Y; Wu Y; Wu L; Qin L; Liu T
    J Transl Med; 2022 Nov; 20(1):498. PubMed ID: 36324119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.